BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Feuillet V, Canard B, Trautmann A. Combining Antivirals and Immunomodulators to Fight COVID-19. Trends Immunol 2021;42:31-44. [PMID: 33281063 DOI: 10.1016/j.it.2020.11.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Iacopetta D, Ceramella J, Catalano A, Saturnino C, Pellegrino M, Mariconda A, Longo P, Sinicropi MS, Aquaro S. COVID-19 at a Glance: An Up-to-Date Overview on Variants, Drug Design and Therapies. Viruses 2022;14:573. [DOI: 10.3390/v14030573] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
2 Terrier O, Si-Tahar M, Ducatez M, Chevalier C, Pizzorno A, Le Goffic R, Crépin T, Simon G, Naffakh N. Influenza viruses and coronaviruses: Knowns, unknowns, and common research challenges. PLoS Pathog 2021;17:e1010106. [PMID: 34969061 DOI: 10.1371/journal.ppat.1010106] [Reference Citation Analysis]
3 Mahroum N, Zoubi M, Lavine N, Ohayon A, Amital H, Shoenfeld Y. The mosaic of autoimmunity - A taste for more. The 12th international congress of autoimmunity 2021 (AUTO12) virtual. Autoimmun Rev 2021;20:102945. [PMID: 34509655 DOI: 10.1016/j.autrev.2021.102945] [Reference Citation Analysis]
4 Soares S, Bornet M, Grosso C, Ramalhosa MJ, Gouvinhas I, Garcia J, Rodrigues F, Delerue-matos C. Honey as an Adjuvant in the Treatment of COVID-19 Infection: A Review. Applied Sciences 2022;12:7800. [DOI: 10.3390/app12157800] [Reference Citation Analysis]
5 Chavda VP, Kapadia C, Soni S, Prajapati R, Chauhan SC, Yallapu MM, Apostolopoulos V. A global picture: therapeutic perspectives for COVID-19. Immunotherapy. [DOI: 10.2217/imt-2021-0168] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 13.0] [Reference Citation Analysis]
6 Arora G, Joshi J, Mandal RS, Shrivastava N, Virmani R, Sethi T. Artificial Intelligence in Surveillance, Diagnosis, Drug Discovery and Vaccine Development against COVID-19. Pathogens 2021;10:1048. [PMID: 34451513 DOI: 10.3390/pathogens10081048] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 He Y, Qu J, Wei L, Liao S, Zheng N, Liu Y, Wang X, Jing Y, Shen CK, Ji C, Luo G, Zhang Y, Xiang Q, Fu Y, Li S, Fan Y, Fang S, Wang P, Li L. Generation and Effect Testing of a SARS-CoV-2 RBD-Targeted Polyclonal Therapeutic Antibody Based on a 2-D Airway Organoid Screening System. Front Immunol 2021;12:689065. [PMID: 34733269 DOI: 10.3389/fimmu.2021.689065] [Reference Citation Analysis]
8 Khamis F, Al Arimi Z, Al Naamani H, Al Bahrani M, Pandak N, Al Bolushi Z, Deenadayalan SS, Al Lawati A, Al Salmi I, Al-Zakwani I. Convalescent Plasma Therapy in Critically Ill COVID-19 Patients: An Open Label Trial. Oman Med J 2021;36:e296. [PMID: 34631155 DOI: 10.5001/omj.2021.105] [Reference Citation Analysis]
9 Pandolfi S, Valdenassi L, Bjørklund G, Chirumbolo S, Lysiuk R, Lenchyk L, Doşa MD, Fazio S. COVID-19 Medical and Pharmacological Management in the European Countries Compared to Italy: An Overview. IJERPH 2022;19:4262. [DOI: 10.3390/ijerph19074262] [Reference Citation Analysis]
10 Faist A, Janowski J, Kumar S, Hinse S, Çalışkan DM, Lange J, Ludwig S, Brunotte L. Virus Infection and Systemic Inflammation: Lessons Learnt from COVID-19 and Beyond. Cells 2022;11:2198. [DOI: 10.3390/cells11142198] [Reference Citation Analysis]
11 Wong CKH, Lau KTK, Au ICH, Xiong X, Chung MSH, Lau EHY, Cowling BJ. Optimal timing of remdesivir initiation in hospitalized COVID-19 patients administered with dexamethasone. Clin Infect Dis 2021:ciab728. [PMID: 34420051 DOI: 10.1093/cid/ciab728] [Reference Citation Analysis]
12 Wong CKH, Lau KTK, Au ICH, Xiong X, Chung MSH, Leung BYC, Lau EHY, Cowling BJ. Initiation of Tocilizumab or Baricitinib Were Associated With Comparable Clinical Outcomes Among Patients Hospitalized With COVID-19 and Treated With Dexamethasone. Front Pharmacol 2022;13:866441. [DOI: 10.3389/fphar.2022.866441] [Reference Citation Analysis]
13 Hakovirta H, Jalkanen J, Saimanen E, Kukkonen T, Romsi P, Suominen V, Vikatmaa L, Valtonen M, Karvonen MK, Venermo M; INFORAAA Study Group. Induction of CD73 prevents death after emergency open aortic surgery for a ruptured abdominal aortic aneurysm: a randomized, double-blind, placebo-controlled study. Sci Rep 2022;12:1839. [PMID: 35115574 DOI: 10.1038/s41598-022-05771-1] [Reference Citation Analysis]
14 Spicer AJ, Jalkanen S. Why Haven't We Found an Effective Treatment for COVID-19? Front Immunol 2021;12:644850. [PMID: 33868280 DOI: 10.3389/fimmu.2021.644850] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Trautmann A. [Mechanisms underlying chronic fatigue, a symptom too often overlooked]. Med Sci (Paris) 2021;37:910-9. [PMID: 34647880 DOI: 10.1051/medsci/2021143] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Xu X, Jiang W, Chen L, Xu Z, Zhang Q, Zhu M, Ye P, Li H, Yu L, Zhou X, Zhou C, Chen X, Zheng X, Xu K, Cai H, Zheng S, Jiang W, Wu X, Li D, Chen L, Luo Q, Wang Y, Qu J, Li Y, Zheng W, Jiang Y, Tang L, Xiang C, Li L. Evaluation of the safety and efficacy of using human menstrual blood-derived mesenchymal stromal cells in treating severe and critically ill COVID-19 patients: An exploratory clinical trial. Clin Transl Med 2021;11:e297. [PMID: 33634996 DOI: 10.1002/ctm2.297] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
17 Aricò E, Bracci L, Castiello L, Urbani F, Casanova JL, Belardelli F. Exploiting natural antiviral immunity for the control of pandemics: Lessons from Covid-19. Cytokine Growth Factor Rev 2021:S1359-6101(21)00092-7. [PMID: 34955389 DOI: 10.1016/j.cytogfr.2021.12.001] [Reference Citation Analysis]
18 Zheng W, Wu H, Wang T, Zhan S, Liu X. Quercetin for COVID-19 and DENGUE co-infection: a potential therapeutic strategy of targeting critical host signal pathways triggered by SARS-CoV-2 and DENV. Brief Bioinform 2021:bbab199. [PMID: 34058750 DOI: 10.1093/bib/bbab199] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Pitsillou E, Liang J, Hung A, Karagiannis TC. The SARS-CoV-2 helicase as a target for antiviral therapy: Identification of potential small molecule inhibitors by in silico modelling. Journal of Molecular Graphics and Modelling 2022;114:108193. [DOI: 10.1016/j.jmgm.2022.108193] [Reference Citation Analysis]